cbdMD Inc (YCBD): Next-Year EPS Estimate 63.16%
As of 2026-06-11, cbdMD Inc (YCBD) has a next-year EPS growth estimate of 63.16%.
On 2026-05-17, analyst consensus for YCBD's next-year EPS growth shifted from 50.00% to 63.16% — a positive change of 13.16 percentage points. The revised estimate has been sustained across 20 subsequent trading sessions. Current-year growth is projected at 82.57%.
Current Snapshot
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- EPS growth next year
- 63.16%
- EPS growth this year
- 82.57%
- EPS next quarter (est)
- -$0.03
- Last price
- $0.70
EPS Revision History
| Date | EPS Next Y | EPS This Y | Next Q (est) | Price |
|---|---|---|---|---|
| 2026-06-11 | 63.16% | 82.57% | -$0.03 | $0.70 |
| 2026-06-10 | 63.16% | 82.57% | -$0.03 | $0.69 |
| 2026-06-09 | 63.16% | 82.57% | -$0.03 | $0.71 |
| 2026-06-08 | 63.16% | 82.57% | -$0.03 | $0.72 |
| 2026-06-07 | 63.16% | 82.57% | -$0.03 | $0.72 |
| 2026-06-04 | 63.16% | 82.57% | -$0.03 | $0.75 |
| 2026-06-03 | 63.16% | 82.57% | -$0.03 | $0.70 |
| 2026-06-02 | 63.16% | 82.57% | -$0.03 | $0.75 |
| 2026-06-01 | 63.16% | 82.57% | -$0.03 | $0.79 |
| 2026-05-31 | 63.16% | 82.57% | -$0.03 | $0.79 |
| 2026-05-28 | 63.16% | 82.57% | -$0.03 | $0.83 |
| 2026-05-27 | 63.16% | 82.57% | -$0.03 | $0.76 |
| 2026-05-26 | 63.16% | 82.57% | -$0.03 | $0.76 |
| 2026-05-25 | 63.16% | 82.57% | -$0.03 | $0.76 |
| 2026-05-24 | 63.16% | 82.57% | -$0.03 | $0.76 |
| 2026-05-21 | 63.16% | 82.57% | -$0.03 | $0.78 |
| 2026-05-20 | 63.16% | 82.57% | -$0.03 | $0.75 |
| 2026-05-19 | 63.16% | 82.57% | -$0.03 | $0.75 |
| 2026-05-18 | 63.16% | 82.57% | -$0.03 | $0.77 |
| 2026-05-17 | 63.16% | 82.57% | -$0.03 | $0.77 |
| 2026-05-14 | 50.00% | 87.16% | -$0.05 | $0.81 |
| 2026-05-13 | 50.00% | 87.16% | -$0.05 | $0.79 |
| 2026-05-12 | 50.00% | 87.16% | -$0.05 | $0.78 |
| 2026-05-11 | 50.00% | 87.16% | -$0.05 | $0.81 |
| 2026-05-10 | 50.00% | 87.16% | -$0.05 | $0.84 |
| 2026-05-07 | 50.00% | 87.16% | -$0.05 | $0.87 |
| 2026-05-06 | 50.00% | 87.16% | -$0.05 | $0.91 |
| 2026-05-05 | 50.00% | 87.16% | -$0.05 | $0.85 |
| 2026-05-04 | 50.00% | 87.16% | -$0.05 | $0.86 |
| 2026-05-03 | 50.00% | 87.16% | -$0.05 | $0.87 |
Screen Performance
Aggregate stats across all 1781 tickers our top-EPS-revision screen has flagged over the past 71 days.
- Median return since detection
- +3.8%
- % of tickers in the green
- 58%
- Median return on winners
- +18.5%
- Large revisions captured
- 788
Past detection performance reflects the price change between when a ticker first entered our screen and the most recent observation. Not a forward-looking forecast.
Frequently Asked Questions
What is cbdMD Inc's next-year EPS growth estimate?▾
As of 2026-06-11, cbdMD Inc (YCBD) has a next-year EPS growth estimate of 63.16%, based on analyst consensus.
When was the latest EPS estimate revision for YCBD?▾
The most recent revision occurred on 2026-05-17, when analysts adjusted the next-year EPS growth estimate from 50.00% to 63.16%.
What sector and industry does cbdMD Inc belong to?▾
cbdMD Inc operates in the Healthcare sector, specifically the Drug Manufacturers - Specialty & Generic industry.
How often is this EPS estimate data updated?▾
EPS revision data is refreshed daily from analyst consensus estimates. YCBD appears on this page because it was flagged by our daily top-EPS-revision-performer screen.
EPS revision data sourced from analyst consensus estimates, refreshed daily. cbdMD Inc (YCBD) appears here because it was detected by our daily top-EPS-revision-performer screen.
← All reports